| INTRODUCTION
Esophageal cancer is a deadly disease with an overall 5 year survival of less than 20%. 1 An important method of treatment involves esophagectomy with esophageal reconstruction by means of a gastric conduit. Over the last decade, the mortality rate associated with esophagectomy has decreased from 8.3% to 4.2%. 2 Analysis of prospective nationwide data, however, demonstrates an associated morbidity rate as high as 50%. 3 Anastomotic leak and stricture constitute common and dreaded sources of surgical morbidity following esophagectomy. Anastomotic complication rates as high as 50% have been reported in some studies with significant associated mortality. [4] [5] [6] Ischemia of the gastric conduit, due to the division of the left gastric and short gastric vessels at the time of conduit creation, contributes to poor anastomotic healing, and subsequent complications. Laparoscopic ischemic conditioning with ligation of these vessels prior to esophagectomy has been proposed to allow neovascularization of the proximal stomach to improve blood flow and decrease the incidence of anastomotic complications.
Preclinical studies have examined the effect of ischemic conditioning on gastric blood flow and esophagogastric anastomotic healing.
Ureschel et al 7 showed that partial ligation of the gastric vessels led to a reduction of anastomotic dehiscence and increase in wound bursting pressures in a rat model. Another study demonstrated that ligation of the left gastric vessels in a rodent model led to an immediate decrease in gastric perfusion that significantly increased after 28 days and leveled off by 56 days after left gastric vessel ligation. 8 Preclinical studies of gastroesophageal anastomotic healing have demonstrated that an ischemic duration of 30 days or greater resulted in increased anastomotic bursting pressure and tensile strength, but that these benefits were not observed with an ischemic conditioning time of 7 days. 9, 10 Taken together, these results suggest that prolonged gastric ischemic conditioning may be of benefit in clinical practice. 12 These studies suggest that the duration of ischemic conditioning may be critical to optimizing its effect on anastomotic healing, and no studies to date have examined the effect of ischemic conditioning beyond 2 weeks before esophagectomy.
Consequently, the aim of this study was to assess the effect of prolonged ischemic conditioning prior to esophagectomy. Our primary endpoint was the degree of neovascularization at the tip of the gastric conduit. Secondary outcomes included operative and postoperative outcomes after esophagectomy.
| MATERIAL AND METHODS
This study involved two tertiary care medical centers. Informed consent was obtained and procedures followed were in accordance with the ethical standards, as approved by institutional review boards at both institutions. A retrospective review of a prospectively maintained esophageal disease registry was performed. We identified all patients undergoing esophagectomy with reconstruction between July 2008
and January 2014 at both institutions. Patients who had adequate tissue available for histopathologic analysis were included in the study. Only patients with tissue blocks from the distal gastric conduit were included.
Twenty-one patients were identified with esophageal cancer who underwent partial or complete laparoscopic ischemic conditioning prior to esophagectomy. These patients were compared to nine control patients, who underwent esophagectomy for cancer without laparo- Laparoscopy was performed, using five trocars. Starting in the right upper quadrant, all the peritoneal surfaces, liver surfaces, omentum, and intra-peritoneal organs were systematically examined, and any suspicious deposits were biopsied. Patients in the complete IC group had the left gastric vessel ligated just prior to its branching along the lesser curvature of the stomach, using 10 mm laparoscopic clipappliers. These patients also had their short gastric vessels divided, using laparoscopic ultrasonic shears. The patients in the partial IC group had only the short gastric vessels divided, using ultrasonic shears. At the completion of the staging laparoscopy, a feeding jejunostomy tube was placed in anticipation of esophagectomy.
| Assessment of neovascularization
Esophagectomy specimens from patients who underwent ischemic conditioning prior to esophagectomy were compared to patients who did not undergo ischemic conditioning. Three serial sections from the distal gastric margin of each surgical specimen were examined. This area 392 | on the conduit was representative of the location where the esophagogastric anastomosis was created. All specimens were routinely submitted for pathology review to assure that the distal margins were free of malignancy. Evaluation of the microvascular density was performed as previously described by a single gastrointestinal pathologist who was blinded to all clinical information. 13 Briefly, gross descriptions and cassette keys from the surgical pathology reports of all subjects were reviewed to identify all blocks containing distal margin(s) from the resection specimens. CD34 immunohistochemical stains were performed on all these blocks. Three "hotspots" were identified in the submucosa on each block, and microvessel counts were performed in each at 200× magnification. 14 Vessels with muscular walls
were not counted. The average microvascular density was calculated from counts of the three hotspots on each tissue block.
| Esophagectomy
All 
| Statistical analysis
We compared patient characteristics, procedure details, and postoperative and oncologic outcomes among patients undergoing esophagectomy without ischemic conditioning and those undergoing esophagectomy following ischemic conditioning. Given the small sample size, continuous variables were evaluated for normality, using normal quantile plots. Where normality assumption was reasonable, Student's t-test was used; otherwise, a permutation test was performed. Fischer's exact test was used to compare categorical variables. A two-sided P-value of less than 0.05 was considered significant. The statistical analysis was carried out, using STATA version 14 (StataCorp, College Station, TX).
| RESULTS
A total of 30 esophagectomy specimens were reviewed for the study, with 13 specimens from patients who had complete IC, 8 from patients with partial IC, and 9 patients who did not have IC (control group). Table 1 shows the demographic data amongst the groups. There were no observed differences between groups with respect to age, gender, BMI, cancer subtypes, or pre-operative co-morbidities. Five of the patients from the complete IC group received the procedure because they were determined to be high ischemic risk, and the remaining 16 patients received IC at the time of planned laparoscopy for feeding tube or staging purposes. The majority of the tumors were esophageal adenocarcinoma, with four squamous cell tumors. Twenty-eight of the tumors were located in the distal esophagus, with two mid esophageal squamous cell lesions.
Twenty-five of the thirty patients were treated with neoadjuvant chemoradiotherapy prior to esophagectomy, and IC patients tended to receive neoadjuvant therapy more commonly than controls (P = 0.02).
ASA class was lower in patients undergoing complete IC than those of the control and partial IC (P = 0.01, Table 1 ). Patients in the control group also had a lower clinical stage, compared to those in the partial IC and complete IC groups (P = 0.02), but there were no significant differences in the final pathologic staging (P = 0.51). Table 2 shows the operative and postoperative data for patients in the partial and complete IC groups.
Operative time for the complete IC procedure tended to be longer compared to partial IC, but this did not reach significance (P = 0.06).
Length of hospital stay, 30-day morbidity, and 30-day mortality were not significantly different between the partial and complete IC groups. There was no procedural morbidity or mortality.
The average ischemic conditioning time prior to esophagectomy was 121 (±105) days for both groups, combined with the shortest duration being 8 days and the longest 533 days. The partial IC group averaged 163 (±156) days and the complete IC group averaged 95 (±50) days (P = 0.33, Table 2 ). CD34 immunostaining showed a 29% increase in microvessel counts in patients undergoing partial IC, as compared to controls (P = 0.3, Fig. 1 ). Complete IC produced a 67% increase in microvessel counts, compared to controls (P < 0.0001), and a 29% increase in microvessel counts over the partial IC group (P = 0.05, Fig. 1 ).
All patients who underwent ischemic conditioning went on to have minimally invasive esophagectomy. Table 3 (Table 3) . There were no
conversions to an open procedure, and no observed differences in blood loss, operative IV fluid administration, length of stay, R0 resection margin status, or lymph node harvest among the patients undergoing esophagectomy following ischemic conditioning versus controls (Table 3) . Thirty-day mortality rates were not statistically different amongst the groups. There was no difference in overall 30 day morbidity that included infectious complications, respiratory distress requiring reintubation, myocardial infarction, deep venous thrombosis, anastomotic complications, and supraventricular tachycardia. Specifically, looking at anastomotic complications, there was no difference between leak (P = 0.58) and stricture rates (P = 0.61) among the three groups (Table 3) . It is well established that gastric conduit ischemia is a major contributor to anastomotic complications. 18 As a result, a number of techniques have been devised to improve blood flow to the gastric conduit. These methods include anastomosing donor vessels to the gastric circulation, use of a pedicled omental flap around the anastomosis, phlebotomy through the short gastric veins to decrease vascular congestion, and delayed anastomosis with gastric ischemic conditioning. 19 The basis of ischemic conditioning is that perfusion to conduit tip can be enhanced by ligation of select vessels to the stomach prior to esophagogastrostomy, allowing new microcirculation to develop to the gastric fundus at the site of the anastomosis. A recent review on the topic of microcirculation following ischemic conditioning found ten studies that demonstrated improved circulation at the gastric conduit tip following ischemic conditioning. 19 There were a number of different methods used to assess the significance. 23 In a small, single institution randomized control trial of laparoscopic ischemic conditioning with a 2 week conditioning interval, there were no complications attributed to the ischemic conditioning procedures. In the 16 patients randomized to ischemic conditioning group, however, the perfusion of the gastric conduit had not returned to baseline, and there were no differences in anastomotic complications noted. 11 The most common reason cited for the short duration of ischemic conditioning in these studies was the risk of scaring that would interfere with the ability to perform esophagectomy safely. In contrast, the present study indicates that longer ischemic conditioning periods (average 121 days) do not interfere with subsequent esophagectomy.
Such clinical studies involving ischemic conditioning of the stomach have failed to consistently demonstrate significant reductions in anastomotic complication rates. One recent meta-analysis attempted to identify technical factors that are associated with anastomotic integrity following esophagectomy. This review identified 12 studies, compromising over 1200 patients. 24 In patients undergoing ischemic preconditioning, anastomotic leak rates were 8.8% versus 14.1% in controls, although this failed to meet significance (P = 0.1). 24 Based on these findings, the authors could not recommend ischemic conditioning for all patients, but did acknowledge that an individualized approach to each patient's physiology and esophageal cancer stage is the most important factor to achieve the best anastomotic integrity after esophagectomy. Another recent systematic review examined clinical studies of ischemic conditioning, and concluded that there was no evidence that gastric ischemic conditioning decreased anastomotic complications. 25 The authors, however, noted that the study with the longest mean ischemic conditioning time was only 15.5 days. 23 Finally, a review of 11 clinical studies identified only six studies that demonstrated decreased anastomotic leak rate with a laparoscopic ischemic preconditioning procedure, and one study that actually demonstrated increased leak rates with the preconditioning procedure. 26 Again, the mean duration from preconditioning to esophagectomy was short, ranging from 4 days to 2 weeks. 26 It is possible that these trials failed to demonstrate improved anastomotic outcomes due to insufficient duration of ischemic conditioning to allow for neovascularization to develop and for gastric perfusion to improve.
In our study, the mean interval between ischemic conditioning and esophagectomy was 121 days, but did have a broad range (8-533 days). The vast majority of patients received preconditioning prior to neoadjuvant chemoradiotherapy. Three patients, however, received ischemic conditioning after neoadjuvant therapy, and therefore had shorter intervals between preconditioning and esophagectomy. One patient who received the ischemic conditioning procedure prior to neoadjuvant therapy had significant delay, due to complications associated with systemic therapy, thus a prolonged ischemic conditioning period. Nonetheless, in our study, the interval between ischemic conditioning and surgery was significantly longer on average than seen in prior analyzes. Going forward, randomized trials of prolonged ischemic conditioning may be the best option to demonstrate reduced anastomotic complications, compared to short interval ischemic conditioning.
Although our findings provide objective evidence that prolonged laparoscopic ischemic conditioning is safe and induces neovascularization of the gastric conduit, there are important weaknesses that must be addressed. The most important outcome that cannot be adequately addressed in this study is the subsequent rate of anastomotic complications. The reason for this is that our study cohort was too small, and only two patients developed anastomotic leaks, both of which lead to anastomotic strictures that improved with dilation. In addition, it would have been prudent to demonstrate that the observed neovascularization was accompanied by a return of perfusion to near baseline levels. No direct measurement of perfusion was taken in our study, but it has been previously demonstrated that increased histologic microvascular density of gastric mucosa is directly correlated with in vivo measures of perfusion. 27 Despite these weaknesses, the data presented can be used as a foundation for the development of larger prospective multi-center studies of laparoscopic prolonged ischemic conditioning, where anastomotic outcomes can be correlated to neovascularization and perfusion of the gastric conduit.
| CONCLUSIONS
Prolonged laparoscopic gastric ischemic conditioning induces neovascularization in the gastric conduit. The greatest increase in neovascularization is seen with the ligation of both the short and left gastric vessels. In addition, prolonged laparoscopic gastric ischemic conditioning is feasible, safe, and did not interfere with subsequent minimally invasive esophagectomy. had full access to all of the data in the study, and takes responsibility for the integrity of the data and the accuracy of the data analysis.
